2016-21877. Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals  

  • Start Preamble Start Printed Page 62743

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    FDA PRA Staff, Office of Operations, Food and Drug Administration, Three White Flint North, 11601 Landsdown St., North Bethesda, MD 20852, PRAStaff@fda.hhs.gov.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the Internet at http://www.reginfo.gov/​public/​do/​PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.

    Table 1—List of Information Collections Approved by OMB

    Title of collectionOMB control No.Date approval expires
    Reporting Associated with New Animal Drug Applications0910-00328/31/2019
    Administrative Detention and Banned Medical Devices0910-01148/31/2019
    Registration of Food Facilities0910-05028/31/2019
    Inspection by Accredited Persons Program Under the Medical Device User Fee and Modernization Act of 20020910-05108/31/2019
    Medical Device User Fee Cover Sheet—FDA Form 36010910-05118/31/2019
    Guidance on Informed Consent for in Vitro Diagnostic Studies Using Leftover Human Specimens That Are Not Individually Identifiable0910-05828/31/2019
    Guidance for Reagents for Detection of Specific Novel Influenza A Viruses0910-05848/31/2019
    Guidance: Emergency Use Authorization of Medical Products0910-05958/31/2019
    Prevention of Salmonella Enteritidis in Shell Eggs During Production—Recordkeeping and Registration Provisions0910-06608/31/2019
    Information to Accompany Humanitarian Device Exemption Applications and Annual Distribution Number Reporting Requirements0910-06618/31/2019
    Guidance for Center for Devices and Radiological Health Appeals Processes0910-07388/31/2019
    Deeming Tobacco Products To Be Subject to the FD&C Act0910-07688/31/2019
    Food Labeling: Revision of the Nutrition Facts Label and Supplement Facts Label0910-08137/31/2019
    Start Signature

    Dated: September 6, 2016.

    Leslie Kux,

    Associate Commissioner for Policy.

    End Signature End Supplemental Information

    [FR Doc. 2016-21877 Filed 9-9-16; 8:45 am]

    BILLING CODE 4164-01-P

Document Information

Published:
09/12/2016
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
2016-21877
Pages:
62743-62743 (1 pages)
Docket Numbers:
Docket Nos. FDA-2016-N-0628, FDA-2012-N-0306, FDA-2002-N-0323, FDA-2012-N-0427, FDA-2012-N-0536, FDA-2012-N-0560, FDA-2015-N-3662, FDA-2012-N-0976, FDA-2013-N-0297, FDA-2012-N-1203, FDA-2011-D-0893, FDA-2014-N-0189, FDA-2012-N-1210
PDF File:
2016-21877.pdf